Last reviewed · How we verify
Pseudomonas urinary tract infection
Approved treatments
- Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria. - Fetroja · Shionogi
Fetroja works by binding to penicillin-binding proteins on bacterial cell walls, inhibiting cell wall synthesis and ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pseudomonas urinary tract infection patent landscape — cliff calendar, originator estates, attackable patents
- Pseudomonas urinary tract infection treatment landscape brief
- Pseudomonas urinary tract infection treatment updates RSS
Frequently asked questions about Pseudomonas urinary tract infection
What drugs treat Pseudomonas urinary tract infection?
Tracked treatments include Recarbrio, Fetroja.
What is the treatment for Pseudomonas urinary tract infection?
Standard treatment for Pseudomonas urinary tract infection includes Recarbrio, Fetroja. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pseudomonas urinary tract infection patent cliff · Pseudomonas urinary tract infection CI report
- Treatment: Recarbrio · Merck & Co.
- Treatment: Fetroja · Shionogi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing